Suppr超能文献

亨廷顿病转基因小鼠模型中下丘脑兴奋性毒性的作用

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease.

作者信息

Henningsen Jo B, Soylu-Kucharz Rana, Björkqvist Maria, Petersén Åsa

机构信息

Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund University, 22184, Lund, Sweden.

Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, 2200, Copenhagen, Denmark.

出版信息

Heliyon. 2021 Aug 14;7(8):e07808. doi: 10.1016/j.heliyon.2021.e07808. eCollection 2021 Aug.

Abstract

Huntington disease (HD) is a fatal neurodegenerative movement disorder caused by an expanded CAG repeat in the huntingtin gene (HTT). The mutant huntingtin protein is ubiquitously expressed, but only certain brain regions are affected. The hypothalamus has emerged as an important area of pathology with selective loss of neurons expressing the neuropeptides orexin (hypocretin), oxytocin and vasopressin in human postmortem HD tissue. Hypothalamic changes in HD may have implications for early disease manifestations affecting the regulation of sleep, emotions and metabolism. The underlying mechanisms of selective vulnerability of certain neurons in HD are not fully understood, but excitotoxicity has been proposed to play a role. Further understanding of mechanisms rendering neurons sensitive to mutant huntingtin may reveal novel targets for therapeutic interventions. In the present study, we wanted to examine whether transgenic HD mice display altered sensitivity to excitotoxicity in the hypothalamus. We first assessed effects of hypothalamic injections of the excitotoxin quinolinic acid (QA) into wild-type (WT) mice. We show that neuronal populations expressing melanin-concentrating hormone (MCH) and cocaine and amphetamine-regulated transcript (CART) display a dose-dependent sensitivity to QA. In contrast, neuronal populations expressing orexin, oxytocin, vasopressin as well as tyrosine hydroxylase in the A13 area are resistant to QA-induced toxicity. We demonstrate that the R6/2 transgenic mouse model expressing a short fragment of mutant HTT displays hypothalamic neuropathology with discrete loss of the neuronal populations expressing orexin, MCH, CART, and orexin at 12 weeks of age. The BACHD mouse model expressing full-length mutant HTT does not display any hypothalamic neuropathology at 2 months of age. There was no effect of hypothalamic injections of QA on the neuronal populations expressing orexin, MCH, CART or oxytocin in neither HD mouse model. In conclusion, we find no support for a role of excitotoxicity in the loss of hypothalamic neuronal populations in HD.

摘要

亨廷顿舞蹈症(HD)是一种由亨廷顿基因(HTT)中CAG重复序列扩增引起的致命性神经退行性运动障碍。突变的亨廷顿蛋白在全身广泛表达,但仅特定脑区会受到影响。下丘脑已成为病理学上的一个重要区域,在人类HD死后组织中,表达神经肽食欲素(下丘脑分泌素)、催产素和加压素的神经元会选择性丧失。HD患者下丘脑的变化可能与影响睡眠、情绪和新陈代谢调节的早期疾病表现有关。HD中某些神经元选择性易损性的潜在机制尚未完全明确,但有人提出兴奋毒性在其中发挥作用。进一步了解使神经元对突变亨廷顿蛋白敏感的机制可能会揭示治疗干预的新靶点。在本研究中,我们想研究转基因HD小鼠在下丘脑中对兴奋毒性的敏感性是否改变。我们首先评估了向野生型(WT)小鼠下丘脑注射兴奋性毒素喹啉酸(QA)的效果。我们发现,表达促黑素(MCH)以及可卡因和苯丙胺调节转录肽(CART)的神经元群体对QA呈剂量依赖性敏感。相比之下,表达食欲素、催产素、加压素以及A13区酪氨酸羟化酶的神经元群体对QA诱导的毒性具有抗性。我们证明,表达突变HTT短片段的R6/2转基因小鼠模型在12周龄时表现出下丘脑神经病理学改变,表达食欲素、MCH、CART和食欲素的神经元群体离散性丧失。表达全长突变HTT的BACHD小鼠模型在2月龄时未表现出任何下丘脑神经病理学改变。在这两种HD小鼠模型中,下丘脑注射QA对表达食欲素、MCH、CART或催产素的神经元群体均无影响。总之,我们没有发现兴奋毒性在HD下丘脑神经元群体丧失中起作用的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd2/8379469/622b77f42015/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验